Literature DB >> 27231825

Surgeon interrater reliability in the endoscopic assessment of cistern scarring and aqueduct patency.

Lucy He1, Stephen Gannon1, Chevis N Shannon1, Brandon G Rocque2, Jay Riva-Cambrin3, Robert P Naftel1.   

Abstract

OBJECTIVE The success of endoscopic third ventriculostomy with choroid plexus cauterization may have associations with age, etiology of hydrocephalus, previous shunting, cisternal scarring, and possibly aqueduct patency. This study aimed to measure interrater reliability among surgeons in identifying cisternal scarring and aqueduct patency. METHODS Using published definitions of cistern scarring and aqueduct patency, 7 neuroendoscopists with training from Dr. Warf in Uganda and 7 neuroendoscopists who were not trained by Dr. Warf rated cistern status from 30 operative videos and aqueduct patency from 26 operative videos. Interrater agreement was calculated using Fleiss' kappa coefficient (κ). Fisher's 2-tailed exact test was used to identify differences in the rates of agreement between the Warf-trained and nontrained groups compared with Dr. Warf's reference answer. RESULTS Aqueduct status, among all raters, showed substantial agreement with κ = 0.663 (confidence interval [CI] 0.626-0.701); within the trained group and nontrained groups, there was substantial agreement with κ = 0.677 (CI 0.593-0.761) and κ = 0.631 (CI 0.547-0.715), respectively. The identification of cistern scarring was less reliable, with moderate agreement among all raters with κ = 0.536 (CI 0.501-0.571); within the trained group and nontrained groups, there was moderate agreement with κ = 0.555 (CI 0.477-0.633) and κ = 0.542 (CI 0.464-0.620), respectively. There was no statistically significant difference in the amount of agreement between groups compared with Dr. Warf's reference. CONCLUSIONS Regardless of training with Dr. Warf, all neuroendoscopists could identify scarred cisterns and aqueduct patency with similar reliability, emphasizing the strength of the published definitions. This makes the identification of this risk factor for failure generalizable for surgical decision making and research studies.

Entities:  

Keywords:  CPC = choroid plexus cauterization; ETV = endoscopic third ventriculostomy; choroid plexus cauterization; endoscopic third ventriculostomy; hydrocephalus; risk factors

Mesh:

Year:  2016        PMID: 27231825      PMCID: PMC5434973          DOI: 10.3171/2016.3.PEDS15648

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  12 in total

1.  Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1968-10       Impact factor: 17.737

2.  Hydrocephalus in Uganda: the predominance of infectious origin and primary management with endoscopic third ventriculostomy.

Authors:  Benjamin C Warf
Journal:  J Neurosurg       Date:  2005-01       Impact factor: 5.115

3.  Long-term outcome for endoscopic third ventriculostomy alone or in combination with choroid plexus cauterization for congenital aqueductal stenosis in African infants.

Authors:  Benjamin C Warf; Sarah Tracy; John Mugamba
Journal:  J Neurosurg Pediatr       Date:  2012-06-29       Impact factor: 2.375

4.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

5.  Initial experience with combined endoscopic third ventriculostomy and choroid plexus cauterization for post-hemorrhagic hydrocephalus of prematurity: the importance of prepontine cistern status and the predictive value of FIESTA MRI imaging.

Authors:  Benjamin C Warf; Jeffrey W Campbell; Eric Riddle
Journal:  Childs Nerv Syst       Date:  2011-05-10       Impact factor: 1.475

6.  Comparison of endoscopic third ventriculostomy alone and combined with choroid plexus cauterization in infants younger than 1 year of age: a prospective study in 550 African children.

Authors:  Benjamin C Warf
Journal:  J Neurosurg       Date:  2005-12       Impact factor: 5.115

7.  Reopening of an obstructed third ventriculostomy: long-term success and factors affecting outcome in 215 infants.

Authors:  Paul J Marano; Scellig S D Stone; John Mugamba; Peter Ssenyonga; Ezra B Warf; Benjamin C Warf
Journal:  J Neurosurg Pediatr       Date:  2015-02-06       Impact factor: 2.375

8.  Endoscopic third ventriculostomy in the treatment of childhood hydrocephalus.

Authors:  Abhaya V Kulkarni; James M Drake; Conor L Mallucci; Spyros Sgouros; Jonathan Roth; Shlomi Constantini
Journal:  J Pediatr       Date:  2009-05-15       Impact factor: 4.406

9.  Combined endoscopic third ventriculostomy and choroid plexus cauterization as primary treatment for infant hydrocephalus: a prospective North American series.

Authors:  Scellig S D Stone; Benjamin C Warf
Journal:  J Neurosurg Pediatr       Date:  2014-08-29       Impact factor: 2.375

10.  Combined endoscopic third ventriculostomy and choroid plexus cauterization as primary treatment of hydrocephalus for infants with myelomeningocele: long-term results of a prospective intent-to-treat study in 115 East African infants.

Authors:  Benjamin C Warf; Jeffrey W Campbell
Journal:  J Neurosurg Pediatr       Date:  2008-11       Impact factor: 2.375

View more
  2 in total

1.  Adverse event detection by medical record review is reproducible, but the assessment of their preventability is not.

Authors:  Dorthe O Klein; Roger J M W Rennenberg; Richard P Koopmans; Martin H Prins
Journal:  PLoS One       Date:  2018-11-29       Impact factor: 3.240

2.  The CURE Protocol: evaluation and external validation of a new public health strategy for treating paediatric hydrocephalus in low-resource settings.

Authors:  Jacob R Lepard; Michael C Dewan; Stephanie H Chen; Olufemi B Bankole; John Mugamba; Peter Ssenyonga; Abhaya V Kulkarni; Benjamin C Warf
Journal:  BMJ Glob Health       Date:  2020-02-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.